University of Nottingham spin-out business, Exonate, which specialises in the discovery and development of novel drugs, has received funding of over £400,000 from Fusion IP PLC, IP Group PLC, The University of Nottingham and a syndicate of business angels, including the newly formed Nottingham Angels Network.